ASH Announces New ASH-Harold Amos Medical Faculty Development Program Hematology Scholar
(WASHINGTON, August 21, 2024) — The ÎÚÑ»´«Ã½ (ASH) is pleased to announce the recipient of the ASH-Harold Amos Medical Faculty Development Program award, Michelle Schoettler, MD, of Children’s Healthcare of Atlanta’s Aflac Cancer and Blood Disorders Center and Emory University.
The ASH-Harold Amos Medical Faculty Development Program award is a partnership between ASH and the Robert Wood Johnson Foundation that aims to increase the number of faculty in hematology from historically marginalized backgrounds. Recipients are granted a total of $420,000 over the four years of the program, including stipends, research support, a National Advisory Committee mentor, complimentary ASH membership, and support for attendance at both the ASH and Harold Amos Medical Faculty Development Program annual meetings each year of the award.
“ASH is proud to continue its long-standing efforts to foster and empower a diverse new generation of hematology professionals,” said Mohandas Narla, DSc, of New York Blood Center Enterprises. “We look forward to supporting and celebrating Dr. Schoettler’s work as an ASH awardee.”
Dr. Michelle Schoettler is a pediatric bone marrow transplant physician scientist at Children’s Healthcare of Atlanta and assistant professor of pediatrics in the Emory University School of Medicine. Her research aims to improve outcomes for patients with transplant-associated thrombotic microangiopathy (TA-TMA), a life-threatening condition that can lead to multiorgan failure or death. She is leading a multi-institutional study to determine real world responses and outcomes to the best available therapy, eculizumab; validate an early biomarker panel which predicts severe TA-TMA to inform pre-emptive approaches; and investigate the safety and efficacy of novel therapeutic approaches for the disease.
The ASH-Harold Amos Medical Faculty Development Program is part of the ASH Hematology Inclusion Pathway, a comprehensive 13-year longitudinal career pathway of awards that strives to ensure that hematology reflects and serves the diverse world we live in – from medical students to mid-career professionals.
Now in its 41st year, the of the Robert Wood Johnson Foundation welcomed its first cohort of physicians in 1983, with the commitment to mentor individuals from historically marginalized backgrounds to become leaders in academic medicine and science. Over the years, more than three-quarters of the program’s alumni scholars have remained in academic medicine, including 126 professors, 96 associate professors, and 67 assistant professors, as of June 2024. In 2006, ASH became the first professional society to partner with the program, leading to the creation of the ASH-Harold Amos Medical Faculty Development Program award, which has since been awarded to 24 hematology scholars and researchers from historically disadvantaged backgrounds. Learn more about the ASH-Harold Amos Medical Faculty Development Program.
Through various programs and committees, ASH continues its commitment to combating inequities in hematology, supporting scientists and clinicians from backgrounds underrepresented in hematology, embracing diverse voices, and creating greater opportunities for deserving individuals in the field. Learn more about ASH’s commitment to diversity, equity, and inclusion in health care.
The ÎÚÑ»´«Ã½ (ASH) (hematology.org) is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. Since 1958, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology.
Contact:
Melissa McGue, ÎÚÑ»´«Ã½
[email protected], 202-552-4927